Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Construction of folate-conjugated pRNA of bacteriophage phi29 DNA packaging motor for delivery of chimeric siRNA to nasopharyngeal carcinoma cells

A Corrigendum to this article was published on 17 October 2006

Abstract

Nasopharyngeal carcinoma is a poorly differentiated upper respiratory tract cancer that highly expresses human folate receptors (hFR). Binding of folate to hFR triggers endocytosis. The folate was conjugated into adenosine 5′-monophosphate (AMP) by 1,6-hexanediamine linkages. After reverse HPLC to reach 93% purity, the folate–AMP, which can only be used for transcription initiation but not for chain extension, was incorporated into the 5′-end of bacteriophage phi29 motor pRNA. A 16:1 ratio of folate–AMP to ATP in transcription resulted in more than 60% of the pRNA containing folate. A pRNA with a 5′-overhang is needed to enhance the accessibility of the 5′ folate for specific receptor binding. Utilizing the engineered left/right interlocking loops, polyvalent dimeric pRNA nanoparticles were constructed using RNA nanotechnology to carry folate, a detection marker, and siRNA targeting at an antiapoptosis factor. The chimeric pRNAs were processed into ds-siRNA by Dicer. Incubation of nasopharyngeal epidermal carcinoma (KB) cells with the dimer resulted in its entry into cancer cells, and the subsequent silencing of the target gene. Such a protein-free RNA nanoparticle with undetectable antigenicity has a potential for repeated long-term administration for nasopharyngeal carcinoma as the effectiveness and specificity were confirmed by ex vivo delivery in the animal trial.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  1. Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T . Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 2001; 411: 494–498.

    Article  CAS  PubMed  Google Scholar 

  2. Ryther RC, Flynt AS, Phillips III JA, Patton JG . siRNA therapeutics: big potential from small RNAs. Gene Therapy 2005; 12: 5–11.

    Article  CAS  PubMed  Google Scholar 

  3. Li H, Li WX, Ding SW . Induction and suppression of RNA silencing by an animal virus. Science 2002; 296: 1319–1321.

    Article  CAS  PubMed  Google Scholar 

  4. Brummelkamp TR, Bernards R, Agami R . A system for stable expression of short interfering RNAs in mammalian cells. Science 2002; 296: 550–553.

    Article  CAS  PubMed  Google Scholar 

  5. Carmichael GG . Medicine: silencing viruses with RNA. Nature 2002; 418: 379–380.

    Article  CAS  PubMed  Google Scholar 

  6. Rossi JJ . Ribozyme therapy for HIV infection. Adv Drug Deliv Rev 2000; 44: 71–78.

    Article  CAS  PubMed  Google Scholar 

  7. Devroe E, Silver PA . Therapeutic potential of retroviral RNAi vectors. Expert Opin Biol Ther 2004; 4: 319–327.

    Article  CAS  PubMed  Google Scholar 

  8. Morrissey DV, Lockridge JA, Shaw L, Blanchard K, Jensen K, Breen W et al. Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs. Nat Biotechnol 2005; 23: 1002–1007.

    Article  CAS  PubMed  Google Scholar 

  9. Soutschek J, Akinc A, Bramlage B, Charisse K, Constien R, Donoghue M et al. Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs. Nature 2004; 432: 173–178.

    Article  CAS  PubMed  Google Scholar 

  10. Guo P, Erickson S, Anderson D . A small viral RNA is required for in vitro packaging of bacteriophage φ29 DNA. Science 1987; 236: 690–694.

    Article  CAS  PubMed  Google Scholar 

  11. Guo P . Structure and function of phi29 hexameric RNA that drive viral DNA packaging motor: review. Prog Nucl Acid Res Mole Biol 2002; 72: 415–472.

    Article  CAS  Google Scholar 

  12. Shu D, Moll D, Deng Z, Mao C, Guo P . Bottom-up assembly of RNA arrays and superstructures as potential parts in nanotechnology. Nano Lett 2004; 4: 1717–1724.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Zhang CL, Lee C-S, Guo P . The proximate 5′ and 3′ ends of the 120-base viral RNA (pRNA) are crucial for the packaging of bacteriophage φ29 DNA. Virology 1994; 201: 77–85.

    Article  CAS  PubMed  Google Scholar 

  14. Chen C, Zhang C, Guo P . Sequence requirement for hand-in-hand interaction in formation of pRNA dimers and hexamers to gear phi29 DNA translocation motor. RNA 1999; 5: 805–818.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Zhang CL, Tellinghuisen T, Guo P . Confirmation of the helical structure of the 5′/3′ termini of the essential DNA packaging pRNA of phage φ29. RNA 1995; 1: 1041–1050.

    CAS  PubMed  PubMed Central  Google Scholar 

  16. Hoeprich S, ZHou Q, Guo S, Qi G, Wang Y, Guo P . Bacterial virus phi29 pRNA as a hammerhead ribozyme escort to destroy hepatitis B virus. Gene Therapy 2003; 10: 1258–1267.

    Article  CAS  PubMed  Google Scholar 

  17. Shu D, Huang L, Hoeprich S, Guo P . Construction of phi29 DNA-packaging RNA (pRNA) monomers, dimers and trimers with variable sizes and shapes as potential parts for nano-devices. J Nanosci and Nanotech (JNN) 2003; 3: 295–302.

    Article  CAS  Google Scholar 

  18. Lee RJ, Low PS . Delivery of liposomes into cultured KB cells via folate receptor-mediated endocytosis. J Biol Chem 1994; 269: 3198–3204.

    CAS  PubMed  Google Scholar 

  19. Mathias CJ, Wang S, Lee RJ, Waters DJ, Low PS, Green MA . Tumor-selective radiopharmaceutical targeting via receptor-mediated endocytosis of gallium-67-deferoxamine-folate. J Nucl Med 1996; 37: 1003–1008.

    CAS  PubMed  Google Scholar 

  20. Benns JM, Maheshwari A, Furgeson DY, Mahato RI, Kim SW . Folate-PEG-folate-graft-polyethylenimine-based gene delivery. J Drug Target 2001; 9: 123–139.

    Article  CAS  PubMed  Google Scholar 

  21. Guo S, Tschammer N, Mohammed S, Guo P . Specific delivery of therapeutic RNAs to cancer cells via the dimerization mechanism of phi29 motor pRNA. Human Gene Ther 2005; 16: 1097–1109.

    Article  CAS  Google Scholar 

  22. Khaled A, Guo S, Li F, Guo P . Controllable self-assembly of nanoparticles for specific delivery of multiple therapeutic molecules to cancer cells using RNA nanotechnology. Nano Lett 2005; 5: 1797–1808.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Huang F, Bugg CW, Yarus M . RNA-Catalyzed CoA, NAD, and FAD synthesis from phosphopantetheine, NMN, and FMN. Biochemistry 2000; 39: 15548–15555.

    Article  CAS  PubMed  Google Scholar 

  24. Garver K, Guo P . Boundary of pRNA functional domains and minimum pRNA sequence requirement for specific connector binding and DNA packaging of phage phi29. RNA 1997; 3: 1068–1079.

    CAS  PubMed  PubMed Central  Google Scholar 

  25. Seelig B, Jaschke A . Ternary conjugates of guanosine monophosphate as initiator nucleotides for the enzymatic synthesis of 5′-modified RNAs1. Bioconjug Chem 1999; 10: 371–378.

    Article  CAS  PubMed  Google Scholar 

  26. Huang F . Efficient incorporation of CoA, NAD and FAD into RNA by in vitro transcription. Nucleic Acids Res 2003; 31: e8.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Pan T, Gutell RR, Uhlenbeck OC . Folding of circularly permuted transfer RNAs. Science 1991; 254: 1361–1364.

    Article  CAS  PubMed  Google Scholar 

  28. Hoeprich S, Guo P . Computer modeling of three-dimensional structure of DNA-packaging RNA(pRNA) monomer, dimer, and hexamer of Phi29 DNA packaging motor. J Biol Chem 2002; 277: 20794–20803.

    Article  CAS  PubMed  Google Scholar 

  29. Chen C, Sheng S, Shao Z, Guo P . A dimer as a building block in assembling RNA. A hexamer that gears bacterial virus phi29 DNA-translocating machinery. J Biol Chem 2000; 275 (23): 17510–17516.

    Article  CAS  PubMed  Google Scholar 

  30. Carmell MA, Hannon GJ . RNase III enzymes and the initiation of gene silencing. Nat Struct Mol Biol 2004; 11: 214–218.

    Article  CAS  PubMed  Google Scholar 

  31. Guo P, Zhang C, Chen C, Trottier M, Garver K . Inter-RNA interaction of phage phi29 pRNA to form a hexameric complex for viral DNA transportation. Mol Cell 1998; 2: 149–155.

    Article  CAS  PubMed  Google Scholar 

  32. Huang F, Wang G, Coleman T, Li N . Synthesis of adenosine derivatives as transcription initiators and preparation of 5′ fluorescein- and biotin-labeled RNA through one-step in vitro transcription. RNA 2003; 9: 1562–1570.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

This work was supported mainly by NIH grant R01-EB03730 (Nanoscience and Nanotechnology in Biology and Medicine Program to PG), and partially by NIH grant R01-GM59944 (Institute of General Medicine to PG). We thank Taejin Lee for preparing the data of Figure 4, Philip Low for providing materials and insightful discussions, Paul Robinson for the cytometry assays, Sulma Mohammed for the animal trials, and Jeremy Hall for manuscript preparation.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to P Guo.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Guo, S., Huang, F. & Guo, P. Construction of folate-conjugated pRNA of bacteriophage phi29 DNA packaging motor for delivery of chimeric siRNA to nasopharyngeal carcinoma cells. Gene Ther 13, 814–820 (2006). https://doi.org/10.1038/sj.gt.3302716

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.gt.3302716

Keywords

This article is cited by

Search

Quick links